Quantum-Si (NASDAQ:QSI) CEO Sells $10,083.67 in Stock

Quantum-Si Incorporated (NASDAQ:QSI) CEO Jeffrey Alan Hawkins sold 12,149 shares of Quantum-Si stock in a transaction on Monday, March 23rd. The stock was sold at an average price of $0.83, for a total transaction of $10,083.67. Following the completion of the sale, the chief executive officer owned 3,859,847 shares of the company’s stock, valued at approximately $3,203,673.01. This trade represents a 0.31% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Jeffrey Alan Hawkins also recently made the following trade(s):

• On Friday, March 20th, Jeffrey Alan Hawkins sold 11,628 shares of Quantum-Si stock. The shares were sold at an average price of $0.85, for a total transaction of $9,883.80.

Quantum-Si Stock Performance

QSI opened at $0.85 on Wednesday. The company has a market capitalization of $184.15 million, a P/E ratio of -1.64 and a beta of 3.00. The company has a 50-day moving average of $1.03 and a 200-day moving average of $1.36. Quantum-Si Incorporated has a 1-year low of $0.79 and a 1-year high of $3.10.

Quantum-Si (NASDAQ:QSI) last issued its quarterly earnings results on Tuesday, March 3rd. The company reported ($0.08) EPS for the quarter, topping the consensus estimate of ($0.14) by $0.06. The business had revenue of $0.45 million for the quarter, compared to analysts’ expectations of $0.76 million. Quantum-Si had a negative net margin of 4,160.06% and a negative return on equity of 43.90%. As a group, sell-side analysts expect that Quantum-Si Incorporated will post -0.65 earnings per share for the current fiscal year.

Analysts Set New Price Targets

QSI has been the topic of several research reports. Canaccord Genuity Group dropped their price target on Quantum-Si from $1.50 to $1.00 and set a “hold” rating on the stock in a research report on Wednesday, March 4th. Weiss Ratings reissued a “sell (d-)” rating on shares of Quantum-Si in a report on Monday, December 29th. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Quantum-Si has an average rating of “Hold” and a consensus target price of $3.25.

Institutional Trading of Quantum-Si

Several hedge funds have recently made changes to their positions in QSI. Prudential Financial Inc. bought a new position in Quantum-Si during the 2nd quarter worth $25,000. Curbstone Financial Management Corp bought a new position in shares of Quantum-Si during the fourth quarter worth about $26,000. Capital Investment Advisory Services LLC increased its holdings in shares of Quantum-Si by 100.0% in the 3rd quarter. Capital Investment Advisory Services LLC now owns 20,000 shares of the company’s stock worth $28,000 after acquiring an additional 10,000 shares during the period. Leonteq Securities AG bought a new stake in Quantum-Si in the 4th quarter valued at about $28,000. Finally, Elite Life Management LLC acquired a new position in Quantum-Si during the 3rd quarter valued at about $29,000. Institutional investors own 39.90% of the company’s stock.

Quantum-Si Company Profile

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.